PHOENIX, Ariz. -- April 10, 2015 -- AZ Business magazine has named Dr. Daniel D. Von Hoff of the Translational Genomics Research Institute (TGen) as its 2015 Researcher of the Year.
The magazine -- part of AZ Big Media, which is celebrating "30 Years of Excellence" -- announced Dr. Von Hoff's recognition at its Healthcare Leadership Awards dinner April 9 in Phoenix.
Dr. Von Hoff, M.D., TGen's Distinguished Professor and Physician-In-Chief, directs clinical trials at the Virginia G. Piper Cancer Center Clinical Trials at HonorHealth that translates TGen research discoveries into new treatments for patients.
"I am honored to be named AZ Business magazine's Researcher of the Year, especially in light of the other fine physician-scientists nominated," said Dr. Von Hoff. "Our work in translation of laboratory discoveries into clinical trials is vitally important for the many patients who we all strive to help."
Others nominated for the magazine's Researcher of the Year were: Dr. Glen Weiss, M.D., of Cancer Treatment Centers of America (CTCA) at Western Regional Medical Center (Western) in Goodyear, Ariz.; Dr. David Jacofsky, M.D., Chairman of The CORE Institute.
Keynote speaker at the event was Dr. Connie Mariano, former White House Physician to the President and first woman Director of the White House Medical Unit, whose new book is titled The White House Doctor: My Patients were Presidents.
Also honored at the event for a Lifetime Achievement Award was Peter Fine, President and CEO of Banner Health, and a former executive with health systems in Wisconsin, Illinois and Indiana.
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit: http://www.